Second-generation antipsychotics and the metabolic syndrome Prakash S. MasandRajnish Mago Invited Commentary Pages: 153 - 154
Repetitive transcranial magnetic stimulation and auditory hallucinations Joachim Hallmayer Clinical Trials Report Pages: 159 - 159
Repetitive transcranial magnetic stimulation over temporoparietal cortices in the treatment of refractory auditory hallucinations in patients with schizophrenia Joachim Hallmayer Clinical Trials Report Pages: 160 - 161
Visual hallucinations and the charles bonnet syndrome Dominic H. Ffytche OriginalPaper Pages: 168 - 179
Hallucinations in children and adolescents Morton D. SoslandGail A. Edelsohn OriginalPaper Pages: 180 - 188
The demystification of autoscopic phenomena: Experimental propositions Christine MohrOlaf Blanke OriginalPaper Pages: 189 - 195
Rapid eye movement sleep, non-rapid eye movement sleep, dreams, and hallucinations Raffaele Manni OriginalPaper Pages: 196 - 200
Duloxetine for pain symptoms in patients with major depressive disorder Prakash S. MasandRajnish Mago Clinical Trials Report Pages: 203 - 205
The impact of anxiety and mood disorders on physical disease: The worried not-so-well Richard M. SobelDimitri Markov OriginalPaper Pages: 206 - 212
Interface of women’s mental and reproductive health Sermsak LolakNavid RashidThomas N. Wise OriginalPaper Pages: 220 - 227
Facilitating treatment of anxiety disorders in patients with comorbid medical illness Daniel W. HicksHaniya Raza OriginalPaper Pages: 228 - 235
